Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
page
post
product

Fever, tropical and emerging (FTE)

Real-time efficiency in detecting emerging and tropical pathogens

altona Diagnostics supports laboratories with a focused molecular portfolio for the detection of tropical and emerging pathogens, combining target-specific assay design, flexible workflow integration, and robust real-time PCR performance.

FTE epidemiologic and clinical challenges

Fever, tropical and emerging (FTE) infections remain a growing diagnostic challenge across endemic, subtropical, and temperate regions. Global travel, climate change, and shifting vector distributions continue to expand the need for reliable molecular detection and preparedness.

 

FTE pathogens often present non-specific symptoms, delayed clinical suspicion, and urgent public health implications. Rapid and accurate molecular detection is critical for patient management, outbreak response, surveillance, and preparedness. Diagnostic laboratories need solutions that are specific, flexible, and operationally efficient. That means assay portfolios which can adapt to changing epidemiology while preserving sensitivity, specificity, and laboratory workflow continuity.

What does altona Diagnostics provide?

altona Diagnostics offers a portfolio built around CE-IVD and RUO assays for tropical and emerging infections, including validated targets such as chikungunya, dengue, Zika, West Nile, yellow fever, malaria, Lassa, Rift Valley fever, filovirus screening, CCHF, and Chagas.

 

  • The fever, tropical and emerging infections portfolio delivers CE-IVD marked RT-PCR assays designed for reliable detection, flexible assay combination, and ready-to-use operation with internal and positive controls included.
  • The RUO kits provide real-time PCR reagent systems for research applications, including detection and differentiation of pathogen-specific DNA or RNA. Those kits support research into emerging pathogens, assay development, and non-diagnostic workflows.

The AltoStar® Molecular Diagnostic Workflow can be positioned to support laboratory operations from targeted testing to high-throughput molecular processing.

HIGHLIGHT

Target specific molecular assays

From endemic febrile illnesses to emerging outbreak threats, altona supports laboratories with target-specific, ready-to-use molecular assays for reliale detection and flexible workflow integration.

 

  • Ready-to-use RT-PCR kits with internal control included
  • Flexible assay combinations in a single run
  • High sensitivity and specificity through individually optimized target-specific assays
  • Differentiation capability for pathogen relevant species (e. g. Malaria, Dengue, Filoviruses)
  • Proven field impact demonstrated during recent outbreaks (e. g., 2026 Bundibugyo, see our dedicated solutions for it) and contribution to global programs such as the EYE initiative for yellow fever eradication

All FTE assays

AltoStar® Workflow

Contact sales

FTE brochure